Paula Ragan | executive |
Mark Baldry | executive |
Christophe Arbet-Engels | executive |
Eva Xia Privitera | analyst |
Stephen Willey | analyst |
Edward Tenthoff | analyst |
Andrew Fleszar | analyst |
Kristen Kluska | analyst |
Swayampakula Ramakanth | analyst |
David Bautz | analyst |
Greetings and welcome to X4 Pharmaceuticals' third quarter financial and operating results conference call. [Operator Instructions] As a reminder, this conference is being recorded.It is now my pleasure to introduce your host, Dan Ferry from LifeSci Advisors. Thank you, Mr. Ferry.
You may begin.